Literature DB >> 11150895

Maintenance electroconvulsive therapy in affective and schizoaffective disorder.

E Swoboda1, A Conca, P König, R Waanders, M Hansen.   

Abstract

Twenty-one patients (13 depressives and 8 schizoaffectives) who underwent maintenance electroconvulsive therapy (M-ECT) were compared with controls who received maintenance pharmacotherapy alone. Measures of effectiveness and safety of maintenance treatment were prospectively obtained during a 1-year follow-up. Survival analysis demonstrated a significantly better outcome defined by time to rehospitalization for all patients of the M-ECT group. Regarding the subgroups, depressives of the M-ECT group had markedly decreased rehospitalization rates compared to depressive controls. Furthermore, M-ECT in depressives resulted in a significant reduction in hospitalization rates and duration during follow-up. In schizoaffective patients, a significant difference in survival time was found in favor of the M-ECT group. In both groups, schizoaffectives had a markedly poorer outcome compared to depressive subjects. Our results indicate that in selected patients M-ECT, at least in combination with supporting medication, may be an efficient and safe alternative to pharmacological continuation or maintenance therapy alone. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11150895     DOI: 10.1159/000054861

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  10 in total

Review 1.  Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature.

Authors:  Georgios Petrides; Kristen G Tobias; Charles H Kellner; Matthew V Rudorfer
Journal:  Neuropsychobiology       Date:  2011-07-29       Impact factor: 2.328

Review 2.  Relapse prevention after index electroconvulsive therapy in treatment-resistant depression.

Authors:  Nagy A Youssef; W Vaughn McCall
Journal:  Ann Clin Psychiatry       Date:  2014-11       Impact factor: 1.567

3.  Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas.

Authors:  Diana Kristensen; Jeanett Bauer; Ida Hageman; Martin Balslev Jørgensen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-05       Impact factor: 5.270

Review 4.  Rapid cycling bipolar disease: new concepts and treatments.

Authors:  S L Dubovsky
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 5.285

Review 5.  [Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease].

Authors:  Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Wien Klin Wochenschr       Date:  2003-05-15       Impact factor: 1.704

Review 6.  Electroconvulsive therapy and its different indications.

Authors:  Thomas C Baghai; Hans-Jürgen Möller
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

7.  Electroconvulsive therapy for treatment-resistant schizophrenia.

Authors:  Diarmid Jm Sinclair; Sai Zhao; Fang Qi; Kazare Nyakyoma; Joey Sw Kwong; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

8.  Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results.

Authors:  Iulian Iancu; Nimrod Pick; Orit Seener-Lorsh; Pinhas Dannon
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-27       Impact factor: 2.570

9.  Lorazepam provocation test in purported schizophrenia with lack of treatment response.

Authors:  John E Berg
Journal:  Ment Illn       Date:  2014-12-18

Review 10.  Intractable schizo-affective disorder successfully treated with electroconvulsive treatment over six years.

Authors:  John E Berg
Journal:  Ment Illn       Date:  2012-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.